Why is this phase needed? Management of COPD is variable. Because of the controversy surrounding the use of ICS and LABAs, some patients at enrollment will be taking these medications, while others will not. This phase is to ensure uniformity of therapy (and in particular to the use of ICS in the same dose) for all study participants.